Bence György1, Krisztina Pálóczi2, Alexandra Kovács2, Eszter Barabás3, Gabriella Bekő3, Katalin Várnai3, Éva Pállinger2, Katalin Szabó-Taylor2, Tamás G Szabó2, Attila A Kiss4, András Falus2, Edit I Buzás5. 1. Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary. Electronic address: gyorgyben@gmail.com. 2. Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary. 3. Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary. 4. Military Hospital, National Health Institute, Department of Obstetrics and Gynecology, Budapest, Hungary. 5. Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary. Electronic address: edit.buzas@gmail.com.
Abstract
INTRODUCTION: Recently extracellular vesicles (exosomes, microparticles also referred to as microvesicles and apoptotic bodies) have attracted substantial interest as potential biomarkers and therapeutic vehicles. However, analysis of microparticles in biological fluids is confounded by many factors such as the activation of cells in the blood collection tube that leads to in vitro vesiculation. In this study we aimed at identifying an anticoagulant that prevents in vitro vesiculation in blood plasma samples. MATERIALS AND METHODS: We compared the levels of platelet microparticles and non-platelet-derived microparticles in platelet-free plasma samples of healthy donors. Platelet-free plasma samples were isolated using different anticoagulant tubes, and were analyzed by flow cytometry and Zymuphen assay. The extent of in vitro vesiculation was compared in citrate and acid-citrate-dextrose (ACD) tubes. RESULTS: Agitation and storage of blood samples at 37 °C for 1 hour induced a strong release of both platelet microparticles and non-platelet-derived microparticles. Strikingly, in vitro vesiculation related to blood sample handling and storage was prevented in samples in ACD tubes. Importantly, microparticle levels elevated in vivo remained detectable in ACD tubes. CONCLUSIONS: We propose the general use of the ACD tube instead of other conventional anticoagulant tubes for the assessment of plasma microparticles since it gives a more realistic picture of the in vivo levels of circulating microparticles and does not interfere with downstream protein or RNA analyses.
INTRODUCTION: Recently extracellular vesicles (exosomes, microparticles also referred to as microvesicles and apoptotic bodies) have attracted substantial interest as potential biomarkers and therapeutic vehicles. However, analysis of microparticles in biological fluids is confounded by many factors such as the activation of cells in the blood collection tube that leads to in vitro vesiculation. In this study we aimed at identifying an anticoagulant that prevents in vitro vesiculation in blood plasma samples. MATERIALS AND METHODS: We compared the levels of platelet microparticles and non-platelet-derived microparticles in platelet-free plasma samples of healthy donors. Platelet-free plasma samples were isolated using different anticoagulant tubes, and were analyzed by flow cytometry and Zymuphen assay. The extent of in vitro vesiculation was compared in citrate and acid-citrate-dextrose (ACD) tubes. RESULTS:Agitation and storage of blood samples at 37 °C for 1 hour induced a strong release of both platelet microparticles and non-platelet-derived microparticles. Strikingly, in vitro vesiculation related to blood sample handling and storage was prevented in samples in ACD tubes. Importantly, microparticle levels elevated in vivo remained detectable in ACD tubes. CONCLUSIONS: We propose the general use of the ACD tube instead of other conventional anticoagulant tubes for the assessment of plasma microparticles since it gives a more realistic picture of the in vivo levels of circulating microparticles and does not interfere with downstream protein or RNA analyses.
Authors: Laurent Muller; Chang-Sook Hong; Donna B Stolz; Simon C Watkins; Theresa L Whiteside Journal: J Immunol Methods Date: 2014-06-18 Impact factor: 2.303
Authors: Nikolett Marton; Orsolya Tünde Kovács; Eszter Baricza; Ágnes Kittel; Dávid Győri; Attila Mócsai; Florian M P Meier; Carl S Goodyear; Iain B McInnes; Edit I Buzás; György Nagy Journal: Cell Mol Life Sci Date: 2017-05-10 Impact factor: 9.261
Authors: Bence György; Michelle E Hung; Xandra O Breakefield; Joshua N Leonard Journal: Annu Rev Pharmacol Toxicol Date: 2014-10-03 Impact factor: 13.820
Authors: Anudeep Yekula; Koushik Muralidharan; Keiko M Kang; Lan Wang; Leonora Balaj; Bob S Carter Journal: Methods Date: 2020-02-12 Impact factor: 3.608